MannKind Corporation (NASDAQ:MNKD) released its latest earnings report on May 8, and Wall Street was generally disappointed. However, not everyone is so bearish …
Shares of MannKind Corporation (NASDAQ:MNKD) were hammered today after J.P.
MannKind Corporation (NASDAQ:MNKD) reported first quarter 2015 results on May 7, revealing underwhelming sales and a mediocre Afrezza launch. Shares of MannKind last …
In a research report issued Friday, Piper Jaffray analyst Joshua Schimmer maintained a Neutral rating on MannKind Corporation (NASDAQ:MNKD) and reduced the price …
MannKind Corporation (NASDAQ:MNKD) reported financial results for the first quarter ended March 31, 2015. For the first quarter of 2015, total operating expenses were …
MannKind Corporation (NASDAQ:MNKD) announced that it will begin to manufacture a 12 unit cartridge strength of AFREZZA (insulin human) Inhalation Powder to improve …
MannKind Corporation (NASDAQ:MNKD) announced its fourth quarter fiscal 2014 earnings report on Wednesday, February 24th with results generally in line with expectations. Highlights from the …
J.P.
MLV’s healthcare analyst Arlinda Lee weighed in today with a few insights on MannKind Corporation (NASDAQ:MNKD), after the company reported its fourth-quarter results, posting EPS of …
In a research report published Wednesday, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on MannKind Corporation (NASDAQ:MNKD) with a $7 price target, following …
